BRIEF-Brazil says received request from Bharat Biotech from local phase III Covaxin trials
06 Feb 2021 / 06:35 H.
RIO DE JANEIRO, Feb 5 (Reuters) -
* BRAZILIAN HEALTH REGULATOR ANVISA SAYS HAS RECEIVED REQUEST FROM BHARAT BIOTECH TO CONDUCT PHASE III TRIALS OF COVAXIN VACCINE IN BRAZIL
* (Reporting by Gram Slattery)
Did you like this article?
